DA
TMO icon

Dover Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Dover Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.45M Buy
4,225
+263
+7% +$126K 1% 24
2026
Q1 		$1.95M Sell
3,962
-263
-6% -$143K 0.81% 36
2025
Q4 		$2.45M Buy
4,225
+155
+4% +$87.7K 0.95% 28
2025
Q3 		$1.98M Buy
4,070
+6
+0.1% +$2.79K 0.79% 38
2025
Q2 		$1.65M Sell
4,064
-271
-6% -$113K 0.73% 41
2025
Q1 		$2.16M Buy
4,335
+607
+16% +$329K 0.94% 32
2024
Q4 		$1.94M Buy
3,728
+59
+2% +$32.4K 1.11% 25
2024
Q3 		$2.27M Buy
3,669
+212
+6% +$125K 1.29% 19
2024
Q2 		$1.91M Hold
3,457
– – 1.18% 22
2024
Q1 		$2.01M Buy
3,457
+1,117
+48% +$627K 1.38% 20
2023
Q4 		$1.24M Sell
2,340
-852
-27% -$412K 1.63% 17
2023
Q3 		$1.62M Buy
3,192
+24
+0.8% +$12.8K 1.64% 16
2023
Q2 		$1.65M Buy
3,168
+20
+0.6% +$10.8K 1.47% 19
2023
Q1 		$1.82M Buy
3,148
+379
+14% +$214K 1.75% 14
2022
Q4 		$1.53M Buy
+2,769
New +$1.47M 1.65% 14

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Dover Advisors's TMO Position: Q2 2026 in Review

Dover Advisors increased its Thermo Fisher Scientific (TMO) stake by 6.6% in Q2 2026, buying an estimated $126K and bringing the position to 4,225 shares worth $2.45M. The position accounts for 1% of the portfolio, ranked #24.

Dover Advisors first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Dover Advisors held 4,225 shares of Thermo Fisher Scientific worth $2.45M as of Q2 2026.
  • Dover Advisors bought 263 Thermo Fisher Scientific shares in Q2 2026, an estimated $126K.
  • Thermo Fisher Scientific made up 1% of Dover Advisors's portfolio in Q2 2026, its #24 holding.
  • Dover Advisors first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Dover Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.